Tower Research Capital LLC TRC Buys 2,289 Shares of ModivCare Inc. (NASDAQ:MODV)

Tower Research Capital LLC TRC grew its holdings in shares of ModivCare Inc. (NASDAQ:MODV – Get Rating) by 403.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,857 shares of the company’s stock after purchasing an additional 2,289 shares during the quarter. Tower Research Capital LLC TRC’s holdings in ModivCare were worth $285,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD grew its holdings in ModivCare by 0.5% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 808,041 shares of the company’s stock worth $68,279,000 after acquiring an additional 4,361 shares during the last quarter. State Street Corp boosted its stake in ModivCare by 5.2% during the 2nd quarter. State Street Corp now owns 446,895 shares of the company’s stock valued at $37,763,000 after purchasing an additional 22,164 shares during the last quarter. Aristotle Capital Boston LLC boosted its stake in ModivCare by 4.5% during the 2nd quarter. Aristotle Capital Boston LLC now owns 337,284 shares of the company’s stock valued at $28,500,000 after purchasing an additional 14,622 shares during the last quarter. Neuberger Berman Group LLC boosted its stake in ModivCare by 81.4% during the 1st quarter. Neuberger Berman Group LLC now owns 330,136 shares of the company’s stock valued at $38,094,000 after purchasing an additional 148,191 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in ModivCare by 6.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 327,316 shares of the company’s stock valued at $27,659,000 after purchasing an additional 20,456 shares during the last quarter.

ModivCare Price Performance

Shares of ModivCare stock opened at $97.99 on Friday. ModivCare Inc. has a one year low of $73.06 and a one year high of $121.54. The stock’s fifty day moving average is $99.98 and its 200 day moving average is $97.71. The stock has a market cap of $1.39 billion, a P/E ratio of -43.36, a P/E/G ratio of 1.46 and a beta of 0.66. The company has a debt-to-equity ratio of 2.76, a quick ratio of 0.72 and a current ratio of 0.70.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Deutsche Bank Aktiengesellschaft increased their target price on ModivCare from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Friday, February 24th. Barrington Research increased their price target on ModivCare from $138.00 to $143.00 and gave the company an “outperform” rating in a report on Friday, February 24th.

ModivCare Company Profile

(Get Rating)

ModivCare, Inc provides technology-enabled services, which offers integrated supportive care solutions for public and private payors and their patients. It operates through the following business segments: Non-Emergency Medical Transportation (NEMT), Matrix Investment, and Personal Care. The NEMT segment operates under the brands ModivCare Solutions, LLC, and Circulation and includes the Company’s activities for executive, accounting, finance, internal audit, tax, legal, certain strategic and development functions and the Company’s insurance captive.